Novo Nordisk joins forces with OpenAI to fast-track drug research

Danish pharma company Novo Nordisk has announced a partnership with OpenAI to apply artificial intelligence across its drug development process.

Novo Nordisk joins forces with OpenAI to fast-track drug research
Danish pharma company Novo Nordisk has announced a partnership with OpenAI to apply artificial intelligence across its drug development process.

What's Your Reaction?

like
0
dislike
0
love
0
funny
0
angry
0
sad
0
wow
0